Dr. Reddy's Laboratories declines on the BSE
Dr. Reddy's Laboratories is currently trading at Rs. 1188.85, down by 37.20 points or 3.03% from its previous closing of Rs. 1226.05 on the BSE.
The scrip opened at Rs. 1195.60 and has touched a high and low of Rs. 1221.00 and Rs. 1171.00 respectively. So far 40061 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1420.20 on 21-Aug-2024 and a 52 week low of Rs. 1074.35 on 11-Dec-2023.
Last one week high and low of the scrip stood at Rs. 1299.45 and Rs. 1171.00 respectively. The current market cap of the company is Rs. 99166.63 crore.
The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 49.01% and 10.13% respectively.
Dr. Reddy's Laboratories’ US-based subsidiary -- Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to ‘Failed Impurities/Degradation Specification’. It is also recalling another 532 100-count bottles of the medication in 30 mg strength for the same reason.
Dr Reddy's initiated the Class II nationwide recall on October 22 this year.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
